The growth of the live cell imaging market is attributed to the adoption of high-content screening techniques in drug discovery, the rising prevalence of chronic disease demanding higher and quicker diagnostic facilities, and government funding for cell-based research.
According to the World Health Organization, chronic diseases kill 41 million people each year, equivalent to 71% of all deaths globally. Increased demand for healthcare systems, due to the prevalence of chronic diseases, has become a major concern. Also, increasing age and lifestyle-related chronic diseases are increasing the healthcare demand and spending. In developing markets, cancer and heart diseases are becoming the main causes of death, owing to urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. Due to the increasing prevalence of chronic diseases, there is a high demand for medical devices that enable early detection and quick diagnosis, which could prove to be particularly impactful. Furthermore, government initiatives are also supporting cell-based research which boost this studied market.
Key Market Trends
Equipment Segment Under Product is Expected to Grow Fastest During the Forecast Period
The equipment segment includes microscopes, cell analyzers, image capturing systems, and standalone systems. Recent technological advancements in microscopes have augmented the growth of the market. For instance, an inverted research-grade microscope has supported imaging of adherent cells and organelles and yield results for tissue sections of less than 5 um thickness. The overall industry trend is shifting toward automation, integration of systems, and maximizing data generation from microscopes. According to the World Health Organization, 15 million people die from a chronic disease between the ages of 30 and 69 years every year. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers. Thus, the increasing burden of chronic diseases and the need for the scientist to study the nature and function of cells is boosting the growth of the segment.
North America Region Holds the Largest Market Share of Live Cell Imaging Market Market Currently and is Believed to Follow the Same Trend over the Forecast Period
North America dominated the market. The major share is attributed to the presence of a larger patient pool and increasing geriatric population. The generous investment and funding available for research in live-cell imaging is the key driver in this region. In the North America region, the United States holds the largest market share due to factors such as an increasing number of chronic diseases, along with a growing number of research and development programs in the country. According to the latest estimates from the Centers for Disease Control and Prevention 2018, about 37,832 people received an HIV diagnosis in the United States. As per the statistics the large patient pool and high disposable income, helps government and research organizations to propels the market growth in this region.
The live cell imaging market consists of several major players, including Becton, Dickinson and Company, Carl Zeiss, and Leica Microsystems, among many others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. For instance, in March 2018, Nikon Corporation released a new product new N-SIM S Super-Resolution Microscope, which enables super-solution imaging of live cells at 10 times greater than the speed of conventional structured illumination microscopy (SIM).
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support